nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer
|
Xu, Fu-Guo |
|
2009 |
283 |
2 |
p. 119-124 6 p. |
artikel |
2 |
Effect of pro-inflammatory cytokine stimulation on human breast cancer: Implications of chemokine receptor expression in cancer metastasis
|
Valdivia-Silva, Julio E. |
|
2009 |
283 |
2 |
p. 176-185 10 p. |
artikel |
3 |
Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells
|
Song, Ji-young |
|
2009 |
283 |
2 |
p. 135-142 8 p. |
artikel |
4 |
Growth-inhibitory effects of a mineralized extract from the red marine algae, Lithothamnion calcareum, on Ca2+-sensitive and Ca2+-resistant human colon carcinoma cells
|
Aslam, Muhammad Nadeem |
|
2009 |
283 |
2 |
p. 186-192 7 p. |
artikel |
5 |
Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis
|
Singhal, Sharad S. |
|
2009 |
283 |
2 |
p. 152-158 7 p. |
artikel |
6 |
M2-A induces apoptosis and G2–M arrest via inhibiting PI3K/Akt pathway in HL60 cells
|
Wang, Jin |
|
2009 |
283 |
2 |
p. 193-202 10 p. |
artikel |
7 |
Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2
|
Siegelin, M.D. |
|
2009 |
283 |
2 |
p. 230-238 9 p. |
artikel |
8 |
Oncogenic mutation of PIK3CA in small cell lung carcinoma: A potential therapeutic target pathway for chemotherapy-resistant lung cancer
|
Shibata, Tatsuhiro |
|
2009 |
283 |
2 |
p. 203-211 9 p. |
artikel |
9 |
Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: Association to tumor derived alpha-N-acetylgalactosaminidase activity
|
Greco, Marilena |
|
2009 |
283 |
2 |
p. 222-229 8 p. |
artikel |
10 |
Spontaneous immortalization of oligodendroglial cells derived from an SV40 T antigen-positive human glioblastoma multiforme
|
Kim, Boe-Hyun |
|
2009 |
283 |
2 |
p. 212-221 10 p. |
artikel |
11 |
Src inhibitor dasatinib inhibits growth of breast cancer cells by modulating EGFR signaling
|
Nautiyal, Jyoti |
|
2009 |
283 |
2 |
p. 143-151 9 p. |
artikel |
12 |
Targeting the RAF–MEK–ERK pathway in cancer therapy
|
Montagut, Clara |
|
2009 |
283 |
2 |
p. 125-134 10 p. |
artikel |
13 |
Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner
|
Lima, Luize G. |
|
2009 |
283 |
2 |
p. 168-175 8 p. |
artikel |
14 |
TWEAK promotes ovarian cancer cell metastasis via NF-κB pathway activation and VEGF expression
|
Dai, Lan |
|
2009 |
283 |
2 |
p. 159-167 9 p. |
artikel |